Christopher DeRosa

Helio Genomics, Inc. is a leading healthcare company based in Irvine, CA, that focuses on early cancer detection through cutting-edge research and development. The private company's mission is to simplify cancer screening and enhance patient outcomes across diverse populations. Helio Genomics has pioneered breakthrough innovations in genomics, providing a strong foundation for its sister company, Lamh. Helio Genomics is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw. The company's development program is focused on liver, colon, breast, and lung cancer. The company has R&D, GMP, and CLIA facilities in Irvine, CA, and West Lafayette, IN. The CEO of the company is Justin Chen Li.